App-Quantinova.ai

The use of endometrial biopsy to aid in the diagnostic uncertainty in cases of pregnancy of unknown location: a case series

S.J. Wang - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

Methotrexate

Does an ultrasound diagnosis of ruptured ectopic on transvaginal ultrasound scan correlate with operative and histology findings?

S. Mitchell - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

N/A

A rare case of ovarian clear cell carcinoma in pregnancy

S.J. Wang - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ovarian clear cell carcinoma

N/A

Efficacy of ultrasound subjective pattern recognition for endometrial cancer among Black women presenting with postmenopausal bleeding

M. Wong - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Endometrial Cancer

N/A

Endosketch: the use of 3D model sketch in preoperative consent clinic for endometriosis patients

A. Moneib - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

The prevalence of deep and ovarian endometriosis in premenopausal women: a prospective ultrasound study

P. Chaggar - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

Non-menstrual toxic shock syndrome is challenging for gynecologist

H. Hadawi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hypertension

N/A

Reproductive outcomes in women with borderline ovarian tumours

L. Kasaven - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Comparing pelvic floor findings during pregnancy in nulliparous and in parous women

L. Cattani - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention to Saphenous Venous Graft in Acute Coronary Syndrome

Maria Zakai - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

Alessandro Spirito - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Angiology

Peripheral artery disease

Ticagrelor

Effects of Complete Revascularization According to Age in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel: Insights From the COMPLETE Trial

Kevin Bainey - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Complete Revascularization Versus Culprit Lesion–Only PCI in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: A Subgroup Analysis of the COMPLETE Trial

Zardasht Oqab - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Multi-vessel disease

N/A

Bifurcation Left Main Coronary Stenting With or Without Intracoronary Imaging: Outcomes From the European Bifurcation Club Left Main Trial

Annette Maznyczka - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Complete Revascularisation in Patients Presenting With ST-Segment Elevation MI, Cardiogenic Shock, and Multivessel Disease Is Associated With Higher Mortality at 30 Days, 1 Year, and up to 30 Months of Follow-Up

Alexander Tindale - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Multi-vessel disease

N/A

Using a Protocolized Approach and a Dedicated Shock Team Leads to Significant Reductions in 30-day Mortality in Acute Coronary Syndrome Patients With Cardiogenic Shock

Maria Monteagudo Vela - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Impact of Left Ventricular Ejection Fraction (EF) on 10-Year Mortality After Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG): Is CABG Safer Than PCI in All Patients With Reduced EF?

Patrick Serruys - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Symptom and Physiological Changes After Successful Chronic Total Occlusion Percutaneous Coronary Intervention

Sarosh Khan - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic total occlusion

N/A

Use of Sirolimus-Coated Balloon in De Novo Small-Vessel Coronary Lesions in Acute Coronary Syndrome: Long-Term Follow-Up From a Single-Center Registry

Maria Zakai - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

sirolimus

Contribution of Plaque Composition to the Extent of Plaque Fracture and Dissection Following Drug-Coated Balloon Angioplasty in De Novo Small Vessel Disease: An Interim Report of the TRANSFORM-I Trial

Kai Ninomiya - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

45280 Abstracts